Saumur Darren 4
4 · Genpact LTD · Filed Dec 14, 2022
Insider Transaction Report
Form 4
Saumur Darren
Senior Vice President
Transactions
- Exercise/Conversion
Common Shares
2022-12-12$27.70/sh+40,036$1,108,997→ 135,720 total - Sale
Common Shares
[F1]2022-12-12$45.17/sh−40,036$1,808,262→ 95,684 total - Exercise/Conversion
Employee Stock Option (Right to Buy)
[F2]2022-12-12−40,036→ 60,036 totalExercise: $27.70Exp: 2029-01-09→ Common Shares (40,036 underlying)
Footnotes (2)
- [F1]The price in Column 4 is a weighted average price. The actual sales prices for these transactions ranged from $45.15 to $45.23. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- [F2]The option vested 50% on January 10, 2022, and the remainder will vest on January 10, 2024, subject to the reporting person's continued service through such date.
Signature
/s/ Thomas D. Scholtes, as Attorney-in-fact for Darren Saumur|2022-12-14